rs1059217

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_030777.4(SLC2A10):​c.*2176T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.406 in 152,024 control chromosomes in the GnomAD database, including 12,967 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.41 ( 12967 hom., cov: 32)
Failed GnomAD Quality Control

Consequence

SLC2A10
NM_030777.4 3_prime_UTR

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -2.46

Publications

11 publications found
Variant links:
Genes affected
SLC2A10 (HGNC:13444): (solute carrier family 2 member 10) This gene encodes a member of the class III facilitative glucose transporter family. The encoded protein plays a role in regulation of glucose homeostasis. Mutations in this gene have been associated with arterial tortuosity syndrome.[provided by RefSeq, Dec 2009]
SLC2A10 Gene-Disease associations (from GenCC):
  • arterial tortuosity syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, PanelApp Australia, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen, G2P

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_030777.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BP6
Variant 20-46736010-T-C is Benign according to our data. Variant chr20-46736010-T-C is described in ClinVar as Benign. ClinVar VariationId is 338631.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.586 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_030777.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC2A10
NM_030777.4
MANE Select
c.*2176T>C
3_prime_UTR
Exon 5 of 5NP_110404.1O95528

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC2A10
ENST00000359271.4
TSL:1 MANE Select
c.*2176T>C
3_prime_UTR
Exon 5 of 5ENSP00000352216.2O95528
SLC2A10
ENST00000862794.1
c.*2176T>C
3_prime_UTR
Exon 5 of 5ENSP00000532853.1
SLC2A10
ENST00000862792.1
c.*2176T>C
3_prime_UTR
Exon 6 of 6ENSP00000532851.1

Frequencies

GnomAD3 genomes
AF:
0.406
AC:
61697
AN:
151908
Hom.:
12958
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.317
Gnomad AMI
AF:
0.352
Gnomad AMR
AF:
0.457
Gnomad ASJ
AF:
0.445
Gnomad EAS
AF:
0.604
Gnomad SAS
AF:
0.400
Gnomad FIN
AF:
0.456
Gnomad MID
AF:
0.373
Gnomad NFE
AF:
0.425
Gnomad OTH
AF:
0.424
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AC:
0
AN:
0
Hom.:
0
Cov.:
0
AC XY:
0
AN XY:
0
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome
AF:
0.406
AC:
61736
AN:
152024
Hom.:
12967
Cov.:
32
AF XY:
0.411
AC XY:
30525
AN XY:
74306
show subpopulations
African (AFR)
AF:
0.317
AC:
13150
AN:
41494
American (AMR)
AF:
0.457
AC:
6978
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.445
AC:
1541
AN:
3464
East Asian (EAS)
AF:
0.603
AC:
3118
AN:
5168
South Asian (SAS)
AF:
0.400
AC:
1927
AN:
4816
European-Finnish (FIN)
AF:
0.456
AC:
4802
AN:
10536
Middle Eastern (MID)
AF:
0.390
AC:
114
AN:
292
European-Non Finnish (NFE)
AF:
0.425
AC:
28886
AN:
67952
Other (OTH)
AF:
0.426
AC:
900
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1858
3716
5573
7431
9289
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
580
1160
1740
2320
2900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.411
Hom.:
6195
Bravo
AF:
0.403
Asia WGS
AF:
0.463
AC:
1609
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Arterial tortuosity syndrome (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.97
CADD
Benign
0.16
DANN
Benign
0.35
PhyloP100
-2.5
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs1059217;
hg19: chr20-45364649;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.